Nsmce2-flox Mouse
一般名
Nsmce2-flox
製品ID
S-CKO-14191
背景情報
C57BL/6JCya
系統ID
CKOCMP-68501-Nsmce2-B6J-VA
状況
このマウス系統を論文で使用する場合は、「Nsmce2-flox Mouse(カタログ番号S-CKO-14191)はサイアジェンから購入しました。」と引用してください。
製品タイプ
年齢
遺伝子型
性別
数量
標準的な配送方法では、少なくとも3匹のヘテロ接合体キャリアを保証しています。ホモ接合体キャリアや指定された性別の個体の繁殖サービスも利用可能です。
基本情報
系統名
Nsmce2-flox
系統ID
CKOCMP-68501-Nsmce2-B6J-VA
遺伝子名
製品ID
S-CKO-14191
遺伝子別名
1110014D18Rik
遺伝子別名
C57BL/6JCya
NCBI ID
修正
Conditional knockout
染色体
Chr 15
表現型
アプリケーション
--
さらに
系統詳細
EnsemblトランスクリプトID
ENSMUST00000227173
NCBIトランスクリプトID
NM_001374768
ターゲット領域
Exon 3
有効領域の大きさ
~1.8 kb
遺伝子研究の概要
Nsmce2, also known as Mms21, is an essential SUMO ligase and a subunit of the SMC5/6 complex. The SMC5/6 complex is involved in maintaining chromatin structure, regulating gene expression, and protecting against genomic instability. Nsmce2-related SUMOylation participates in processes like DNA replication, repair, and chromosome segregation [2,3,4,5].
In mouse models, Nsmce2 deletion in adult mice leads to pathologies resembling those in Bloom's syndrome patients, with increased recombination rates and micronuclei accumulation, indicating its role in preventing cancer and aging [2]. In human Nsmce2-deficient cells, collapsed replication forks cannot be rescued effectively, resulting in increased mitotic DNA damage [3]. In zebrafish, knockdown of the Nsmce2 ortholog produces dwarfism [5]. In male germline stem cells of mice, Nsmce2 seems dispensable for proliferation, differentiation, and topological stress relief [7]. In breast cancer, high Nsmce2 expression is linked to poor prognosis and therapy resistance, and decreasing its expression can increase chemotherapy sensitivity [1]. In hepatocellular carcinoma, Nsmce2 promotes tumor development by regulating the SUMOylation of PPARα [6].
In summary, Nsmce2 is crucial for maintaining genomic integrity, playing significant roles in processes such as DNA damage response, cell cycle regulation, and preventing diseases like cancer, aging-related pathologies, and primordial dwarfism. Studies using gene knockout or knockdown models in mice, zebrafish, and cell lines have been instrumental in revealing these functions and their implications in disease, offering potential therapeutic targets for related diseases.
References:
1. Di Benedetto, Carolina, Oh, Justin, Choudhery, Zainab, Valdes, Gilmer, Betancur, Paola. 2022. NSMCE2, a novel super-enhancer-regulated gene, is linked to poor prognosis and therapy resistance in breast cancer. In BMC cancer, 22, 1056. doi:10.1186/s12885-022-10157-7. https://pubmed.ncbi.nlm.nih.gov/36224576/
2. Jacome, Ariana, Gutierrez-Martinez, Paula, Schiavoni, Federica, Blasco, Maria A, Fernandez-Capetillo, Oscar. 2015. NSMCE2 suppresses cancer and aging in mice independently of its SUMO ligase activity. In The EMBO journal, 34, 2604-19. doi:10.15252/embj.201591829. https://pubmed.ncbi.nlm.nih.gov/26443207/
3. Pond, Kelvin W, de Renty, Christelle, Yagle, Mary K, Ellis, Nathan A. 2019. Rescue of collapsed replication forks is dependent on NSMCE2 to prevent mitotic DNA damage. In PLoS genetics, 15, e1007942. doi:10.1371/journal.pgen.1007942. https://pubmed.ncbi.nlm.nih.gov/30735491/
4. Cho, Tiffany, Hoeg, Lisa, Setiaputra, Dheva, Durocher, Daniel. 2024. NFATC2IP is a mediator of SUMO-dependent genome integrity. In Genes & development, 38, 233-252. doi:10.1101/gad.350914.123. https://pubmed.ncbi.nlm.nih.gov/38503515/
5. Payne, Felicity, Colnaghi, Rita, Rocha, Nuno, O'Driscoll, Mark, Semple, Robert. 2014. Hypomorphism in human NSMCE2 linked to primordial dwarfism and insulin resistance. In The Journal of clinical investigation, 124, 4028-38. doi:10.1172/JCI73264. https://pubmed.ncbi.nlm.nih.gov/25105364/
6. Chen, Yukai, Zou, Shishi, Xu, Le, Wei, Yuxin, Xu, Ximing. 2025. NSMCE2 promotes the occurrence and development of HCC by regulating the SUMOylation of PPARα. In International immunopharmacology, 157, 114762. doi:10.1016/j.intimp.2025.114762. https://pubmed.ncbi.nlm.nih.gov/40318278/
7. Zheng, Yi, Jongejan, Aldo, Mulder, Callista L, Li, Jinsong, Hamer, Geert. 2017. Trivial role for NSMCE2 during in vitro proliferation and differentiation of male germline stem cells. In Reproduction (Cambridge, England), 154, 181-195. doi:10.1530/REP-17-0173. https://pubmed.ncbi.nlm.nih.gov/28576919/
品質管理基準
精子検査
凍結前の精子濃度を測定し、精子の生存能力の判定します。
凍結後の精子では、各バッチから1本の凍結保存された精子を選び出し、体外受精に使用します。
環境基準:
SPF対応地域:
グローバル由来:
Cyagenお問い合わせ
カスタムの動物モデルに関するご相談は、下記のフォームにご記入いただき、ご連絡いただくか見積もりをご依頼ください。
Cyagenはお客様のプライバシーを大変重視しています。当社の最新の製品や情報をお届けしたいと思っています。お客様の設定をご確認ください。
これらの配信はいつでも解除できます。配信停止方法およびデータ保護の詳細は プライバシーポリシー をご確認ください。
以下のボタンをクリックすることで、このフォームにご入力いただいた個人情報をCyagenが保存・処理し、ご要望のコンテンツを提供することに同意されたことになります。
